LMNA and laminopathy: On the other hand, a mutated form of prelamin A associated with MADA, as well as a farnesylated form associated with another progeroid laminopathy [103], fail to downregulate TGFbeta 2 causing increase of secreted TGFbeta 2 which, in turn, activates the AKT/mTOR pathway [4].